Literature DB >> 2456308

Inducibility of Ia molecules on keratinocytes reflects genetic control on astrocytes in the brain.

P T Massa1, V ter Meulen.   

Abstract

We have recently observed strain differences in interferon-gamma (IFN-gamma) induction of Ia on astrocytes in rats and mice that are susceptible or resistant to experimental allergic encephalomyelitis (EAE) (Massa et al., 1987). We now found that keratinocytes cultured from rat skin show the same strain differences as astrocytes. Keratinocytes of EAE-susceptible Lewis rats are induced to higher levels of Ia expression compared to relatively resistant Brown-Norway (BN) rats, independent of the dose of IFN-gamma applied. This difference in regulation is specific for class II histocompatibility molecules because no such differences are seen with class I antigen induction by IFN-gamma. That keratinocytes reflect similar strain differences as astrocytes may be explained by a common ectodermal origin of these epithelial-like cells. This observation allows the determination of the genetic predisposition of an autoimmune response in the central nervous system by skin biopsy. This approach may be of importance in studies of immunopathological phenomena of brain tissue in man such as multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456308     DOI: 10.1016/0165-5728(88)90036-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  2 in total

1.  Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.

Authors:  M E Smith; N L Eller; H F McFarland; M K Racke; C S Raine
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

2.  Two sisters with multiple sclerosis, lamellar ichthyosis, beta thalassaemia minor and a deficiency of factor VIII.

Authors:  R Capra; F Mattioli; B Kalman; N Marcianò; A Berenzi; A Benetti
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.